Method to enhance innate immunity defense mechanisms by treatment with plant-derived alkaloids
OwnerMichael J. Gubarev, Elena Y. Enioutinainventors
Life of this patent
Estimating the term…
Loading patent…
OwnerMichael J. Gubarev, Elena Y. Enioutinainventors
Estimating the term…
The present invention relates to a method for enhancing innate immunity defense mechanisms of vertebrate animals including humans. In accordance with the present invention, innate immunity defenses are enhanced by the administration of plant-derived immunomodulators. These plant-derived immunomodulators may be plant tissues, plant extracts containing steroid-like glycoalkaloids, or plant-derived glycoalkaloids. The administration of these immunomodulators significant augments the antimicrobial activities of the innate immune system. The glycoalkaloids useful for the present invention have the formula R--R.sup.1, wherein R is a mono-, di-, tri- or oligo-saccharide which may optionally be modified with pharmacologically acceptable esters or ethers and R.sup.1 is an aglycon or derivative as defined herein. Preferred plant-derived glycoalkaloids include solanine and chaconine.
A method for enhancing an innate immune response in an individual which comprises administering to the individual an amount of a plant-derived immunomodulator effective to increase the activity of an innate immune defense mechanism in the individual upon infection by an infectious agent,
A method for enhancing an innate immune response in an individual which comprises administering to the individual an amount of a plant-derived immunomodulator effective to increase the activity of an innate immune defense mechanism in the individual upon infection by an infectious agent, wherein the plant-derived immunomodulator is solanine.
A method for enhancing an innate immune response in an individual which comprises administering to the individual an amount of a plant-derived immunomodulator effective to increase the activity of an innate immune defense mechanism in the individual upon infection by an infectious agent, wherein the plant-derived immunomodulator is chaconine.
Dependencies are inferred from the claim text.